Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A prospective open-label parallel-group study to determine effects of etrasimod on pharmacokinetics, safety, and tolerability in subjects with mild, moderate, or severe hepatic impairment

X
Trial Profile

A prospective open-label parallel-group study to determine effects of etrasimod on pharmacokinetics, safety, and tolerability in subjects with mild, moderate, or severe hepatic impairment

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Etrasimod (Primary)
  • Indications Alopecia areata; Atopic dermatitis; Autoimmune disorders; Crohn's disease; Eosinophilic oesophagitis; Inflammation; Ulcerative colitis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 07 Dec 2021 New trial record
    • 27 Oct 2021 Results assessing the effect of hepatic impairment on the PK, safety, and tolerability of etrasimod, presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top